Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC02314 is a long intergenic non-protein coding RNA gene that produces a non-coding RNA transcript and does not encode a protein. It belongs to the family of long non-coding RNAs (lncRNAs), specifically classified as a lincRNA, which are RNA molecules longer than 200 nucleotides located between protein-coding genes. While lincRNAs in general have diverse biological roles—such as fine-tuning gene expression, influencing chromatin states, and participating in transcriptional regulation—there are currently no studies establishing a specific molecular or disease function for LINC02314 individually. No drugs are documented to target this RNA and it is not categorized as a receptor, enzyme, or traditional therapeutic target. Its biological relevance may relate to general lincRNA mechanisms rather than a distinct, characterized action.
Not applicable (no known therapeutics target LINC02314)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2314 (LINC02314).